248 related articles for article (PubMed ID: 33986994)
1. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
Yang L; Yin W; Liu X; Li F; Ma L; Wang D; Li H
PeerJ; 2021; 9():e11273. PubMed ID: 33986994
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
Front Genet; 2020; 11():575762. PubMed ID: 33505422
[TBL] [Abstract][Full Text] [Related]
4. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
5. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
6. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
7. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
8. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
9. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
Zhou L; Du Y; Kong L; Zhang X; Chen Q
Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
[TBL] [Abstract][Full Text] [Related]
11. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
12. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
[TBL] [Abstract][Full Text] [Related]
13. Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.
Zheng Y; Liu Y; Zhao S; Zheng Z; Shen C; An L; Yuan Y
Cancer Manag Res; 2018; 10():6079-6096. PubMed ID: 30538557
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
Zhu W; Ru L; Ma Z
Front Oncol; 2021; 11():626654. PubMed ID: 33777771
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
16. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
PeerJ; 2020; 8():e9201. PubMed ID: 32518728
[TBL] [Abstract][Full Text] [Related]
18. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract][Full Text] [Related]
19. Identifying potential prognosis markers in hepatocellular carcinoma
Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
Front Genet; 2022; 13():942454. PubMed ID: 35928445
[No Abstract] [Full Text] [Related]
20. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
